FineMark National Bank & Trust’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$392K Sell
4,725
-76
-2% -$6.3K 0.01% 336
2025
Q1
$389K Sell
4,801
-110
-2% -$8.92K 0.01% 324
2024
Q4
$442K Sell
4,911
-200
-4% -$18K 0.02% 297
2024
Q3
$505K Sell
5,111
-150
-3% -$14.8K 0.02% 284
2024
Q2
$488K Hold
5,261
0.02% 278
2024
Q1
$499K Buy
5,261
+385
+8% +$36.5K 0.02% 282
2023
Q4
$435K Hold
4,876
0.02% 290
2023
Q3
$356K Sell
4,876
-81
-2% -$5.92K 0.02% 307
2023
Q2
$412K Buy
+4,957
New +$412K 0.02% 300
2023
Q1
Sell
-2,714
Closed -$225K 439
2022
Q4
$225K Buy
+2,714
New +$225K 0.01% 362
2022
Q2
Sell
-2,644
Closed -$238K 455
2022
Q1
$238K Buy
2,644
+28
+1% +$2.52K 0.01% 399
2021
Q4
$293K Hold
2,616
0.01% 386
2021
Q3
$329K Buy
2,616
+76
+3% +$9.56K 0.01% 345
2021
Q2
$344K Sell
2,540
-43
-2% -$5.82K 0.01% 345
2021
Q1
$350K Buy
2,583
+258
+11% +$35K 0.01% 329
2020
Q4
$327K Buy
+2,325
New +$327K 0.01% 325
2018
Q3
Sell
-5,160
Closed -$491K 411
2018
Q2
$491K Hold
5,160
0.03% 250
2018
Q1
$453K Hold
5,160
0.03% 261
2017
Q4
$438K Hold
5,160
0.03% 249
2017
Q3
$447K Sell
5,160
-50
-1% -$4.33K 0.03% 248
2017
Q2
$402K Buy
5,210
+360
+7% +$27.8K 0.03% 251
2017
Q1
$336K Buy
4,850
+50
+1% +$3.46K 0.02% 274
2016
Q4
$284K Hold
4,800
0.02% 289
2016
Q3
$318K Hold
4,800
0.03% 266
2016
Q2
$260K Hold
4,800
0.03% 280
2016
Q1
$248K Hold
4,800
0.03% 282
2015
Q4
$337K Hold
4,800
0.04% 247
2015
Q3
$299K Sell
4,800
-3,090
-39% -$192K 0.04% 271
2015
Q2
$663K Buy
7,890
+600
+8% +$50.4K 0.09% 184
2015
Q1
$548K Buy
7,290
+2,400
+49% +$180K 0.07% 208
2014
Q4
$304K Hold
4,890
0.04% 278
2014
Q3
$254K Hold
4,890
0.04% 295
2014
Q2
$251K Hold
4,890
0.04% 295
2014
Q1
$232K Hold
4,890
0.04% 294
2013
Q4
$212K Buy
4,890
+240
+5% +$10.4K 0.04% 298
2013
Q3
$200K Buy
+4,650
New +$200K 0.05% 299